Life ScienceCompany
PDL BioPharma M&A Summary
PDL BioPharma has acquired 4 companies. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
It’s largest disclosed sale occurred in 2020, when it sold Noden Pharma DAC to Stanley Capital for $53M. PDL BioPharma has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).
PDL BioPharma Business Overview
Where is PDL BioPharma headquartered?
PDL BioPharma is headquartered in Incline Village, Nevada.
What is PDL BioPharma’s revenue?
PDL BioPharma disclosed revenue of 55M USD for 2019 and 196M USD for 2018.
How many employees does PDL BioPharma have?
PDL BioPharma has 109 employees.
What sector is PDL BioPharma in?
PDL BioPharma is a life science company.
When was PDL BioPharma founded?
PDL BioPharma was founded in 1986.
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity4
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 3